Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T18:21:56.204Z.
Calculation as of: 2026-10-06T18:21:56.204Z.
Quote observation: 2026-10-06T18:20:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 19f1946388931e4ee5326c5171249fc23a65b0c9e42408d49e268755c1a57655
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-03-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
6.09x
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$942.38M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$912.83M
EV/FCF Ratio
18.02x
TTM Avg
12.91x
3Y Avg
14.88x
5Y Avg
16.28x
Market Cap
$976.29M
EV/FCF Ratio
6.59x
TTM Avg
9.54x
3Y Avg
10.29x
5Y Avg
18.38x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kura Oncology, Inc. (KURA) | $938.35M | N/A | 6.09x | N/A | N/A |
| CeriBell, Inc. (CBLL)vs › | $934.97M | N/A | N/A | N/A | N/A |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $942.38M | N/A | N/A | N/A | N/A |
| MoonLake Immunotherapeutics (MLTX)vs › | $930.32M | N/A | N/A | N/A | N/A |
| Savara Inc. (SVRA)vs › | $953.94M | N/A | N/A | N/A | N/A |
| HealthStream, Inc. (HSTM)vs › | $912.83M | 18.02x | 12.91x | 14.88x | 16.28x |
| Aktis Oncology, Inc. (AKTS)vs › | $968.76M | N/A | N/A | N/A | N/A |
| Pacira BioSciences, Inc. (PCRX)vs › | $976.29M | 6.59x | 9.54x | 10.29x | 18.38x |
| Bioventus Inc. (BVS)vs › | $898.66M | 12.02x | 13.69x | 60.52x | 99.98x |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $987.62M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2026-03-05 | 8.06x |
| 2026-03-04 | 8.10x |
| 2026-03-03 | 8.05x |
| 2026-03-02 | 8.24x |
| 2026-02-27 | 8.29x |
| 2026-02-26 | 8.21x |
| 2026-02-25 | 8.11x |
| 2026-02-24 | 7.92x |
| 2026-02-23 | 7.89x |
| 2026-02-20 | 8.01x |
| 2026-02-19 | 8.14x |
| 2026-02-18 | 8.04x |
| 2026-02-17 | 8.03x |
| 2026-02-13 | 7.85x |
| 2026-02-12 | 7.55x |
| 2026-02-11 | 7.36x |
| 2026-02-10 | 7.36x |
| 2026-02-09 | 7.28x |
| 2026-02-06 | 7.34x |
| 2026-02-05 | 6.89x |
| 2026-02-04 | 7.60x |
| 2026-02-03 | 7.77x |
| 2026-02-02 | 7.81x |
| 2026-01-30 | 7.65x |
| 2026-01-29 | 7.76x |
| 2026-01-28 | 7.57x |
| 2026-01-27 | 8.02x |
| 2026-01-26 | 8.13x |
| 2026-01-23 | 8.19x |
| 2026-01-22 | 8.67x |
| 2026-01-21 | 8.28x |
| 2026-01-20 | 8.16x |
| 2026-01-16 | 8.01x |
| 2026-01-15 | 8.48x |
| 2026-01-14 | 8.96x |
| 2026-01-13 | 8.80x |
| 2026-01-12 | 8.76x |
| 2026-01-09 | 9.01x |
| 2026-01-08 | 9.16x |
| 2026-01-07 | 9.60x |
| 2026-01-06 | 9.15x |
| 2026-01-05 | 9.15x |
| 2026-01-02 | 9.99x |
| 2025-12-31 | 10.04x |
| 2025-12-30 | 9.87x |
| 2025-12-29 | 10.11x |
| 2025-12-26 | 10.30x |
| 2025-12-24 | 10.75x |
| 2025-12-23 | 10.47x |
| 2025-12-22 | 10.97x |
| 2025-12-19 | 9.46x |
| 2025-12-18 | 9.48x |
| 2025-12-17 | 9.82x |
| 2025-12-16 | 10.30x |
| 2025-12-15 | 10.22x |
| 2025-12-12 | 9.87x |
| 2025-12-11 | 10.12x |
| 2025-12-10 | 10.41x |
| 2025-12-09 | 10.34x |
| 2025-12-08 | 11.36x |
| 2025-12-05 | 11.69x |
| 2025-12-04 | 11.72x |
| 2025-12-03 | 11.71x |
| 2025-12-02 | 10.82x |
| 2025-12-01 | 11.15x |
| 2025-11-28 | 11.89x |
| 2025-11-26 | 11.73x |
| 2025-11-25 | 11.32x |
| 2025-11-24 | 11.46x |
| 2025-11-21 | 10.87x |
| 2025-11-20 | 10.67x |
| 2025-11-19 | 11.03x |
| 2025-11-18 | 10.77x |
| 2025-11-17 | 10.53x |
| 2025-11-14 | 10.91x |
| 2025-11-13 | 10.35x |
| 2025-11-12 | 10.35x |
| 2025-11-11 | 10.36x |
| 2025-11-10 | 9.97x |
| 2025-11-07 | 9.49x |
| 2025-11-06 | 9.80x |
| 2025-11-05 | 9.57x |
| 2025-11-04 | 6.59x |
| 2025-11-03 | 6.46x |
| 2025-10-31 | 6.81x |
| 2025-10-30 | 6.93x |
| 2025-10-29 | 6.81x |
| 2025-10-28 | 6.98x |
| 2025-10-27 | 7.36x |
| 2025-10-24 | 6.41x |
| 2025-10-23 | 5.98x |
| 2025-10-22 | 6.11x |
| 2025-10-21 | 6.32x |
| 2025-10-20 | 6.61x |
| 2025-10-17 | 6.51x |
| 2025-10-16 | 6.71x |
| 2025-10-15 | 6.83x |
| 2025-10-14 | 6.35x |
| 2025-10-13 | 6.57x |
| 2025-10-10 | 6.51x |
| 2025-10-09 | 6.80x |
| 2025-10-08 | 6.68x |
| 2025-10-07 | 6.21x |
| 2025-10-06 | 6.48x |
| 2025-10-03 | 6.31x |
| 2025-10-02 | 6.01x |
| 2025-10-01 | 6.05x |
| 2025-09-30 | 5.80x |
| 2025-09-29 | 5.89x |
| 2025-09-26 | 5.94x |
| 2025-09-25 | 5.45x |
| 2025-09-24 | 5.47x |
| 2025-09-23 | 5.37x |
| 2025-09-22 | 5.26x |
| 2025-09-19 | 5.37x |
| 2025-09-18 | 5.51x |
| 2025-09-17 | 5.26x |
| 2025-09-16 | 5.44x |
| 2025-09-15 | 5.34x |
| 2025-09-12 | 5.33x |
| 2025-09-11 | 5.78x |
| 2025-09-10 | 5.32x |
| 2025-09-09 | 5.20x |
| 2025-09-08 | 5.29x |
| 2025-09-05 | 5.35x |
| 2025-09-04 | 5.29x |
| 2025-09-03 | 5.50x |
| 2025-09-02 | 5.16x |
| 2025-08-29 | 5.12x |
| 2025-08-28 | 5.24x |
| 2025-08-27 | 5.09x |
| 2025-08-26 | 4.90x |
| 2025-08-25 | 4.94x |
| 2025-08-22 | 4.94x |
| 2025-08-21 | 4.80x |
| 2025-08-20 | 4.52x |
| 2025-08-19 | 4.62x |
| 2025-08-18 | 4.82x |
| 2025-08-15 | 4.72x |
| 2025-08-14 | 4.20x |
| 2025-08-13 | 4.12x |
| 2025-08-12 | 3.91x |
| 2025-08-11 | 3.44x |
| 2025-08-08 | 3.44x |
| 2025-08-07 | 4.42x |
| 2025-08-06 | 4.48x |
| 2025-08-05 | 4.74x |
| 2025-08-04 | 4.71x |
| 2025-08-01 | 4.47x |
| 2025-07-31 | 4.50x |
| 2025-07-30 | 4.69x |
| 2025-07-29 | 4.75x |
| 2025-07-28 | 4.61x |
| 2025-07-25 | 4.64x |
| 2025-07-24 | 4.83x |
| 2025-07-23 | 4.80x |
| 2025-07-22 | 4.99x |
| 2025-07-21 | 4.83x |
| 2025-07-18 | 4.74x |
| 2025-07-17 | 4.93x |
| 2025-07-16 | 4.76x |
| 2025-07-15 | 4.56x |
| 2025-07-14 | 4.73x |
| 2025-07-11 | 4.68x |
| 2025-07-10 | 4.74x |
| 2025-07-09 | 4.58x |
| 2025-07-08 | 4.31x |
| 2025-07-07 | 4.20x |
| 2025-07-03 | 4.34x |
| 2025-07-02 | 4.31x |
| 2025-07-01 | 4.14x |
| 2025-06-30 | 4.27x |
| 2025-06-27 | 4.19x |
| 2025-06-26 | 4.24x |
| 2025-06-25 | 4.30x |
| 2025-06-24 | 4.44x |
| 2025-06-23 | 4.35x |
| 2025-06-20 | 4.34x |
| 2025-06-18 | 4.50x |
| 2025-06-17 | 4.61x |
| 2025-06-16 | 4.84x |
| 2025-06-13 | 4.80x |
| 2025-06-12 | 4.98x |
| 2025-06-11 | 5.18x |
| 2025-06-10 | 5.10x |
| 2025-06-09 | 5.03x |
| 2025-06-06 | 5.03x |
| 2025-06-05 | 4.91x |
| 2025-06-04 | 4.81x |
| 2025-06-03 | 4.79x |
| 2025-06-02 | 4.69x |
| 2025-05-30 | 4.21x |
| 2025-05-29 | 4.31x |
| 2025-05-28 | 4.10x |
| 2025-05-27 | 4.15x |
| 2025-05-23 | 4.17x |
| 2025-05-22 | 4.65x |
| 2025-05-21 | 4.61x |
| 2025-05-20 | 4.76x |
| 2025-05-19 | 4.65x |
| 2025-05-16 | 4.47x |
| 2025-05-15 | 4.42x |
| 2025-05-14 | 4.24x |
| 2025-05-13 | 4.30x |
| 2025-05-12 | 4.53x |
| 2025-05-09 | 4.27x |
| 2025-05-08 | 4.46x |
| 2025-05-07 | 4.18x |
| 2025-05-06 | 4.29x |
| 2025-05-05 | 5.02x |
| 2025-05-02 | 4.83x |
| 2025-05-01 | 2.67x |
| 2025-04-30 | 2.72x |
| 2025-04-29 | 2.69x |
| 2025-04-28 | 2.69x |
| 2025-04-25 | 2.63x |
| 2025-04-24 | 2.63x |
| 2025-04-23 | 2.59x |
| 2025-04-22 | 2.55x |
| 2025-04-21 | 2.47x |
| 2025-04-17 | 2.29x |
| 2025-04-16 | 2.19x |
| 2025-04-15 | 2.37x |
| 2025-04-14 | 2.26x |
| 2025-04-11 | 2.20x |
| 2025-04-10 | 2.11x |
| 2025-04-09 | 2.33x |
| 2025-04-08 | 2.11x |
| 2025-04-07 | 2.20x |
| 2025-04-04 | 2.28x |
| 2025-04-03 | 2.46x |
| 2025-04-02 | 2.69x |
| 2025-04-01 | 2.60x |
| 2025-03-31 | 2.74x |
| 2025-03-28 | 3.04x |
| 2025-03-27 | 3.10x |
| 2025-03-26 | 3.10x |
| 2025-03-25 | 3.08x |
| 2025-03-24 | 3.43x |
| 2025-03-21 | 3.55x |
| 2025-03-20 | 3.56x |
| 2025-03-19 | 3.18x |
| 2025-03-18 | 3.23x |
| 2025-03-17 | 3.19x |
| 2025-03-14 | 3.10x |
| 2025-03-13 | 3.19x |
| 2025-03-12 | 3.47x |
| 2025-03-11 | 3.22x |
| 2025-03-10 | 3.16x |
| 2025-03-07 | 3.35x |
| 2025-03-06 | 3.46x |
| 2025-03-05 | 3.24x |
| 2025-03-04 | 3.22x |
| 2025-03-03 | 3.17x |
